1. Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
   Mara Massimi et al, 2019, Cells CrossRef
2. Caffeine and its main targets of colorectal cancer
   Wen-Qi Cui et al, 2020, WJGO CrossRef
3. Resveratrol Sensitizes Colorectal Cancer Cells to Cetuximab by Connexin 43 Upregulation-Induced Akt Inhibition
   Yijia Wang et al, 2020, Front. Oncol. CrossRef
4. PDE2 Inhibits PKA-Mediated Phosphorylation of TFAM to Promote Mitochondrial Ca2+-Induced Colorectal Cancer Growth
   Yilin Zhao et al, 2021, Front. Oncol. CrossRef
5. ST08 Altered NF-κB Pathway in Breast Cancer Cells In Vitro as Revealed by miRNA-mRNA Analysis and Enhanced the Effect of Cisplatin on Tumour Reduction in EAC Mouse Model
   Snehal Nirgude et al, 2022, Front. Oncol. CrossRef
6. Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells
   Ling Tong et al, 2022, Front. Oncol. CrossRef
7. Significant position of C-myc in colorectal cancer: a promising therapeutic target
   Li Tan et al, 2022, Clin Transl Oncol CrossRef
8. The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
   Claire Lugnier, 2022, IJMS CrossRef
9. The Therapeutic Effects of Bioactive Compounds on Colorectal Cancer via PI3K/Akt/mTOR Signaling Pathway: A Critical Review
   Kübra Demir et al, 2024, Food Science & Nutrition CrossRef